After underperforming the overall market for the past few years, large-cap pharmaceutical stocks may now be positioned to ...

The Health Care Select Sector SPDR Fund ETF ( NYSEARCA: XLV) rose nearly 4% in the week, outpacing the broader markets. On a ...

Shares of Hikma Pharmaceuticals PLC HIK slid 1.18% to £20.04 Friday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index UKX falling 0.20% to 9,120.31 ...

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their top priorities for the rest of 2025. The 12 executives featured in this article are all speaking at ...

So let's assess the underlying fundamentals over the last 3 years and see if they've moved in lock-step with shareholder returns. This technology could replace computers: discover the 20 stocks are ...

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...

Oregon will receive $10.1 million for drug prevention and treatment services as part of a nationwide settlement with eight ...

New Hampshire will receive $4.5 million over the next 10 years as part of a nationwide opioid settlement involving eight drug companies.

Scheffler headlines the field for next week’s Genesis Scottish Open, which boasts eight of the top-10 players in the world.

While the red-hot Astros continue their ascent up our list, the Rays and Blue Jays are threatening the Yankees in the AL East.

Onyx Storm was the biggest bestseller in the first six months of 2025 as the standard and deluxe editions of the newest book by Rebecca Yarros combined to sell more than 2 million copies.

Why the NFL Is Relaunching Its ‘NFL Top 100’ Series as an X Original The league is turning its annual ranking of the top players into a short-form series on the Elon Musk-owned social platform.